W Rackensperger, R Gaupp, D J Mattke, D Schwarz, K H Stutte. Show Affiliations »
Abstract
Entities: Disease
Mesh: See more » Acute DiseaseAdrenergic beta-Antagonists/pharmacologyAdultBlood Pressure/drug effectsCatatonia/drug therapyClinical Trials as TopicDrug EvaluationFemaleHumansHypertension/chemically inducedMaleOxprenolol/adverse effectsOxprenolol/therapeutic usePropranolol/adverse effectsPropranolol/therapeutic usePsychoses, Substance-Induced/etiologyRemission, SpontaneousSchizophrenia/drug therapySchizophrenia, Disorganized/drug therapySleep Wake Disorders/chemically inducedThirst/drug effects
Substances: See more » Adrenergic beta-AntagonistsOxprenololPropranolol
Year: 1974 PMID: 4152285 DOI: 10.1007/bf00342993
Source DB: PubMed Journal: Arch Psychiatr Nervenkr (1970)